An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality

International Journal of Cancer

Volumn 137, Issue 2, 2015, Pages 428-438

  Slattery, Martha L ^a   Herrick, Jennifer S ^a   Mullany, Lila E ^a   Valeri, Nicola ^b   Stevens, John ^c   Caan, Bette J ^d   Samowitz, Wade ^a   Wolff, Roger K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UTAH STATE UNIVERSITY   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

colorectal cancer; miRNA; survival

Indexed keywords

MICRORNA; MICRORNA 10B 5P; MICRORNA 126 3P; MICRORNA 141 3P; MICRORNA 145 3P; MICRORNA 145 5P; MICRORNA 148A 3P; MICRORNA 151A 3P; MICRORNA 151A 5P; MICRORNA 15B 5P; MICRORNA 16 5P; MICRORNA 18A 5P; MICRORNA 200A 3P; MICRORNA 200A 5P; MICRORNA 200B 3P; MICRORNA 200C 3P; MICRORNA 206; MICRORNA 20A 5P; MICRORNA 20B 5P; MICRORNA 21 3P; MICRORNA 215; MICRORNA 22 3P; MICRORNA 223 3P; MICRORNA 31 5P; MICRORNA 335 5P; MICRORNA 374A 5P; MICRORNA 451A; MICRORNA 570 3P; MICRORNA 9 3P; UNCLASSIFIED DRUG; UNINDEXED DRUG; MIRN145 MICRORNA, HUMAN; MIRN335 MICRORNA, HUMAN; MIRN374 MICRORNA 374, HUMAN; MIRN570 MICRORNA, HUMAN; MIRN92 MICRORNA, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RNA ANALYSIS; RNA REPLICATION; TP53 GENE; AGED; CLINICAL TRIAL; COLORECTAL TUMOR; DNA MICROARRAY; EVALUATION STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEALTH SURVEY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; SURVIVAL; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84929257884     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29384     Document Type: Article

References (51)

1. Michael MZ, SM OC, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882-91.
2. Yang L, Belaguli N, Berger DH,. MicroRNA and colorectal cancer. World J Surg 2009; 33: 638-46.
3. Schepeler T, Reinert JT, Ostenfeld MS, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008; 68: 6416-24.
4. Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-36.
5. Xi Y, Formentini A, Chien M, et al. Prognostic values of microRNAs in colorectal cancer. Biomarker Insights 2006; 2: 113-21.
6. Slattery ML, Potter J, Caan B, et al. Energy balance and colon cancer-beyond physical activity. Cancer Res 1997; 57: 75-80.
7. Slattery ML, Caan BJ, Benson J, et al. Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer 2003; 46: 166-71.
8. Slattery ML, Edwards SL, Palmer L, et al. Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. Mutat Res 2000; 432: 7-14.
9. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005; 129: 837-45.
10. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000; 92: 1831-6.
11. Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (Oxford, England) 2003; 19: 185-93.
12. Griffiths-Jones S,. miRBase: the microRNA sequence database. Methods Mol Biol 2006; 342: 129-38.
13. Tusher VG, Tibshirani R, Chu G,. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-21.
14. Hsu SD, Tseng YT, Shrestha S, et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 2014; 42: D78-85.
15. Dweep H, Sticht C, Pandey P, et al. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011; 44: 839-47.
16. Griffiths-Jones S, Grocock RJ, van Dongen S, et al. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140-4.
17. Huang da W, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
18. Slattery ML, Wolff E, Hoffman MD, et al. MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer 2011; 50: 196-206.
19. Gaedcke J, Grade M, Camps J, et al. The rectal cancer microRNAome-microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res 2012; 18: 4919-30.
20. Cohn DE, Fabbri M, Valeri N, et al. Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol 2010; 202: 656 e1-8.
21. Knowlton DL, Tang K, Henstock PV, et al. miRNA alterations modify kinase activation in the IGF-1 pathway and correlate with colorectal cancer stage and progression in patients. J Cancer 2011; 2: 490-502.
22. Baffa R, Fassan M, Volinia S, et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009; 219: 214-21.
23. Stratmann J, Wang CJ, Gnosa S, et al. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer 2011; 11: 345.
24. Arndt GM, Dossey L, Cullen LM, et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009; 9: 374.
25. Aslam MI, Taylor K, Pringle JH, et al. MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 2009; 96: 702-10.
26. Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008; 105: 13556-61.
27. Valeri N, Croce CM, Fabbri M,. Pathogenetic and clinical relevance of microRNAs in colorectal cancer. Cancer Genomics Proteomics 2009; 6: 195-204.
28. Reid JF, Sokolova V, Zoni E, et al. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res 2012; 10: 504-15.
29. Di Leva G, Croce CM,. miRNA profiling of cancer. Curr Opin Genet Dev 2013; 23: 3-11.
30. Kheirelseid EA, Miller N, Chang KH, et al. mRNA/miRNA correlations in colorectal cancer: novel mechanisms in cancer initiation and progression. Int J Colorectal Dis 2013; 28: 1031-4.
31. Bandres E, Cubedo E, Agirre X, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol cancer 2006; 5: 29.
32. Chen MB, Wei MX, Han JY, et al. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer cells. Cell Signal 2014; 26: 102-109.
33. Christensen LL, Tobiasen H, Holm A, et al. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer 2013; 133: 67-78.
34. Yin J, Bai Z, Song J, et al. Differential expression of serum miR-126, miR-141 and miR-21 as novel biomarkers for early detection of liver metastasis in colorectal cancer. Chin J Cancer Res 2014; 26: 95-103.
35. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-36.
36. Rossi S, Kopetz S, Davuluri R, et al. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol 2010; 42: 1291-97.
37. Valeri N, Gasparini P, Braconi C, et al. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci USA 2010; 107: 21098-103.
38. Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-26.
39. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
40. Slaby O, Svoboda M, Michalek J, et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009; 8: 102.
41. Schetter AJ, Nguyen GH, Bowman ED, et al. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 2009; 15: 5878-87.
42. Ye TT, Yang YL, Liu XY, et al. Prognostic value of circulating microRNA-21 in digestive system cancers: a meta-analysis. Int J Clin Exp Med 2014; 7: 873-8.
43. Masuda S, Izpisua Belmonte JC,. Re: serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 2014; 106: djt457.
44. Toiyama Y, Takahashi M, Hur K, et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 2013; 105: 849-59.
45. Xia X, Yang B, Zhai X, et al. Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. PLoS One 2013; 8: e80426.
46. Nielsen BS, Jorgensen S, Fog JU, et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 2011; 28: 27-38.
47. Liang L, Li X, Zhang X, et al. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology 2013; 144: 624-35 e4.
48. Oliveras-Ferraros C, Cufi S, Vazquez-Martin A, et al. Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFbeta-induced oncomiR miRNA-181a. Cell cycle (Georgetown, Tex) 2011; 10: 1144-51.
49. Tili E, Michaille JJ, Wernicke D, et al. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci USA 2011; 108: 4908-13.
50. Xi Y, Edwards JR, Ju J,. Investigation of miRNA biology by bioinformatic tools and impact of miRNAs in colorectal cancer-regulatory relationship of c-Myc and p53 with miRNAs. Cancer Inform 2007; 3: 245-53.
51. Zhao X, Song H, Zuo Z, et al. Identification of miRNA-miRNA synergistic relationships in colorectal cancer. Int J Biol Macromol 2013; 55: 98-103.